SCHEMBL6959650

SCHEMBL6959650

Cc1ccc(S(=O)(O)=S)c(CCCCc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 3/20 0.41
SIGMAR1 Q99720 1/20 0.41
PTGER1 P34995 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGER3 P43115 1/20 0.40
PTGER2 P43116 1/20 0.40
ASAH1 Q13510 2/20 0.39
LTB4R Q15722 3/20 0.39
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387360 0.97 TDP1 (0.47) TDP1KMT2AMEN1L3MBTL1NPC1
SCHEMBL6604226 0.92 TDP1 (0.43) TDP1KMT2AMEN1L3MBTL1NPC1
SCHEMBL10592891 0.88 AMY1A (0.35) TDP1KMT2AMEN1L3MBTL1POLB
SCHEMBL10590939 0.88 AMY1A (0.35) TDP1KMT2AMEN1L3MBTL1POLB
SCHEMBL6605222 0.87 MEN1 (0.45) TDP1KMT2AMEN1L3MBTL1POLB
SCHEMBL17633979 0.81 AMY1A (0.33) TDP1KMT2APOLBALDH1A1
SCHEMBL5189165 0.80 TDP1 (0.45) TDP1KMT2AMEN1L3MBTL1NPC1
SCHEMBL6605337 0.78 ALDH1A1 (0.41) KMT2AMEN1L3MBTL1NPC1RAB9A
SCHEMBL18917599 0.78 IGF1R (0.40) TDP1KMT2AMEN1NPC1RAB9A
SCHEMBL6962962 0.78 TAAR1 (0.41) KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed